Peptinovo Biopharma
Biotechnology, 600 S Wagner Road, Ann Arbor, Michigan, 48103, United States, 1-10 Employees
Who is PEPTINOVO BIOPHARMA
Chemotherapy is the foundation of cancer treatment because it is so effective, but it is also the downfall of cancer treatment because it is so toxic. Patients can experience hair loss, n...
Read More
-
Headquarters: 600 S Wagner Road, Ann Arbor, Michigan, 48103, United States
-
Date Founded: 2018
-
Employees: 1-10
-
Revenue: Under $1 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 2834
|
NAICS Code: 325412 |
Show More
Does something look wrong? Fix it. | View contact records from PEPTINOVO BIOPHARMA
Peptinovo Biopharma Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Peptinovo Biopharma
Answer: Peptinovo Biopharma's headquarters are located at 600 S Wagner Road, Ann Arbor, Michigan, 48103, United States
Answer: Peptinovo Biopharma's official website is https://peptinovo.com
Answer: Peptinovo Biopharma's revenue is Under $1 Million
Answer: Peptinovo Biopharma's SIC: 2834
Answer: Peptinovo Biopharma's NAICS: 325412
Answer: Peptinovo Biopharma has 1-10 employees
Answer: Peptinovo Biopharma is in Biotechnology
Answer: Peptinovo Biopharma contact info: Phone number: Website: https://peptinovo.com
Answer: Chemotherapy is the foundation of cancer treatment because it is so effective, but it is also the downfall of cancer treatment because it is so toxic. Patients can experience hair loss, nausea, fatigue, aching, or neuropathy and often find that the treatment seems worse than the disease. Imagine the impact a technology would have on cancer treatment if that technology maintains or even improves the efficacy of established chemotherapies without the harmful side effects. And that is what Peptinovo aims to do. Peptinovo Biopharma Inc. has invented and patented a targeted, drug-delivery platform: Peptide-Amphiphile Lipid Micelle (PALM) that reduces or eliminates chemotherapy-induced peripheral neuropathy (CIPN), one of the most serious side effects threatening treatment outcomes for world-leading chemotherapy drugs like paclitaxel. PALM delivers higher doses of proven drugs INTO tumors, keeping them AWAY from healthy tissues. Lives are extended and side effects avoided. Peptinovo is developing its first platform, PNB-281, to eliminate the peripheral neuropathy caused by paclitaxel a world-leading chemotherapy drug used against many major cancers. Peripheral neuropathy is the most serious side-effect threatening the ability to complete the cancer treatment and jeopardizing patients well-being long after the other effects have faded. Peptinovos technology can be used to treat many cancers and it can be used with many chemotherapy drugs. We will initially focus on ovarian cancer patients as paclitaxel chemotherapy is the standard of care and patients often suffer a high degree of the pain, tingling, numbness, and weakness of peripheral neuropathy.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month